Snapdragon Chemistry, Inc.
TrustedTim Jamison, a Professor at MIT’s chemistry department, and Aaron Beeler, an Assistant Professor at Boston University, co-founded Snapdragon Chemistry based on two key revolutionary beliefs:
(1) Continuous flow chemistry should be applied throughout the entire discovery >> development >> manufacturing value chain to gain the technology’s optimal benefits.
(2) Companies need a sophisticated partner that provides end-to-end services to help them implement effective continuous flow solutions.
That is why our company is scientifically-led with a core ethos of unrelenting focus on delivering impact for our clients.
Overview
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 25, 2025 | Cambrex Expands Peptide Manufacturing Capabilities in Waltham, Massachusetts | EAST RUTHERFORD, N.J., Aug. 25, 2025 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced that Snapdragon Chemistry, a Cambrex company, has expanded its active pharmaceutical ... |
| Sep 19, 2024 | Cambrex Announces New Liquid-Phase Peptide Synthesis Manufacturing Technology | EAST RUTHERFORD, N.J., Sept. 19, 2024 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced that Snapdragon Chemistry, a Cambrex company, has successfully developed a new liqui... |
| Oct 25, 2023 | Snapdragon Chemistry, a Cambrex Company, Recognized with CPhI Pharma Award for API Development | EAST RUTHERFORD, N.J, Oct. 25, 2023 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced that Snapdragon Chemistry has been selected as the winner of the API Development Award... |
| May 16, 2023 | Cambrex Completes Expansion of Snapdragon Chemistry Facility in Waltham, Massachusetts | EAST RUTHERFORD, N.J., May 16, 2023 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today... |
| Feb 11, 2022 | Snapdragon Chemistry To Be Acquired by Asymchem | WALTHAM, Mass., Feb. 11, 2022 /PRNewswire/ -- Snapdragon Chemistry today announced its proposed acquisition by Asymchem (stock code: 002821.SZ/6821.HK), a leading CDMO serving the global pharmaceutical and biotech industry. The addition sig... |
| Sep 17, 2021 | A Pfizer partner welcomes ex-ADC Therapeutics CMO Jay Feingold to the team; Amid tough sledding, Immunovant chooses Eli Lilly alum as CFO | Jay Feingold → Last week we told you about the CMO revolving door at ADC Therapeutics, as Joseph Camardo replaced the departing Jay Feingold. The next opportunity for Feingold in the CMO slot has opened up at antibody-dru... |
Reviews 0
FAQ about Snapdragon Chemistry, Inc.
When was Snapdragon Chemistry, Inc. founded?
Snapdragon Chemistry, Inc. was founded in 2014.
What has the press written about Snapdragon Chemistry, Inc.?
Parsers VC has collected 7 articles mentioning Snapdragon Chemistry, Inc., among them “Cambrex Expands Peptide Manufacturing Capabilities in Waltham, Massachusetts” (Aug 25, 2025) and “Cambrex Announces New Liquid-Phase Peptide Synthesis Manufacturing Technology” (Sep 19, 2024).
Is Snapdragon Chemistry, Inc. still active?
Yes, Snapdragon Chemistry, Inc. is active; its latest activity on Parsers VC dates from Jul 7, 2026.